أرسل هذا في رسالة قصيرة: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

  ______   _    _     ______    _____    _    _   
 /_____// | || | ||  /_____//  |  ___|| | || | || 
 `____ `  | || | ||  `____ `   | ||__   | || | || 
 /___//   | \\_/ ||  /___//    | ||__   | \\_/ || 
 `__ `     \____//   `__ `     |_____||  \____//  
 /_//       `---`    /_//      `-----`    `---`   
 `-`                 `-`